Effect of SIRT1 activators and inhibitors on CD44+/CD133+‑enriched non‑small cell lung cancer cellsZühal Eroğlu(Ege University), Zekeriya Düzgün(Giresun University)Molecular Medicine ReportsMay 4, 202010.3892/mmr.2020.11113Cited by 7SaveCiteExport RISWatch citationsRelated PapersInteractions of the Receptor Binding Domain of SARS-CoV-2 Variants with hACE2: Insights from Molecular Docking Analysis and Molecular Dynamic Simulation|Biology|2021|49